Approved indications: Inveltys (loteprednol etabonate ophthalmic suspension 1%) is approved to treat post-operative inflammation and pain after eye (ocular) surgery.

Off-label uses: Other loteprednol eye-drop formulations are more commonly used for chronic inflammatory eye conditions such as allergic or other forms of conjunctivitis, so off-label use of Inveltys itself is limited and evidence is primarily for its approved use after eye surgery.

Efficacy expectations:

• Many patients notice reduced eye pain within a few days of starting the drops, with gradual improvement in redness and swelling over the 2-week treatment period.
• In clinical trials, a higher proportion of patients using Inveltys had complete relief of eye pain by about day 4 and complete resolution of inflammation by about days 8 to 15 compared with placebo (vehicle) drops.
• Overall symptom control is similar to other corticosteroid eye drops used after surgery, but because Inveltys contains loteprednol (a “soft” steroid designed to break down quickly), it may have a somewhat lower risk of steroid-related eye-pressure increases than some older steroids, though monitoring is still important.

Typical dosing and how to use:

• Adults: Instill 1 to 2 drops into the affected eye(s) twice daily, starting the day after surgery and continuing through the first 2 weeks of the post-operative period, or as directed by your eye surgeon.
• Wash your hands before use, shake the bottle for 1 to 2 seconds, tilt your head back, and place the drops into the pocket formed by pulling down the lower eyelid.
• Inveltys is for use in the eye only; do not inject or swallow.
• If you wear soft contact lenses, remove them before using the drops and wait at least 15 minutes before reinserting them.
• If using other eye drops, wait at least 5 minutes between Inveltys and the other medication.

Special dosing instructions: Use exactly as prescribed for the full treatment course even if the eye feels better sooner, do not stop or extend use on your own, and do not let the dropper tip touch your eye, fingers, or any surface to avoid contamination.

Missed dose: If you miss a dose, use it as soon as you remember; if it is almost time for the next dose, skip the missed one and resume your regular schedule—do not use double doses to make up for a missed dose.

Overdose: Accidental use of extra drops in the eye is unlikely to cause serious systemic problems, but if a large amount is accidentally swallowed or if severe eye symptoms occur after overuse, contact a healthcare provider, poison control center, or emergency services for advice.

Common side effects:

• Mild eye pain, irritation, or discomfort shortly after putting in the drops, especially in the early days after surgery.
• Temporary blurred vision or a feeling of something in the eye right after instillation.
• In studies, the most frequent drug-related effects reported were eye pain and clouding of the posterior lens capsule (posterior capsular opacification), which may also be related to the surgery itself.

Serious or rare adverse effects (seek urgent care):

• Sudden change in vision, severe eye pain, halos around lights, or severe eye redness (possible high eye pressure, glaucoma, or other serious eye problems).
• Signs of infection such as increasing redness, swelling, discharge, or worsening pain instead of improvement.
• Allergic reaction symptoms such as rash, swelling around the face or eyelids, or trouble breathing (rare but serious).

Warnings and precautions:

• Eye infections: Do not use if you have most viral eye infections (like herpes simplex keratitis), untreated bacterial or fungal eye infections; steroids can worsen or mask these.
• Eye pressure and glaucoma: Prolonged use of corticosteroid drops can raise eye pressure and contribute to glaucoma; if used for 10 days or longer, eye pressure should be monitored, especially in people with a history of glaucoma.
• Cataracts and healing: Long-term corticosteroid use can promote cataract formation and may slow healing after eye surgery.
• Pregnancy and breastfeeding: Systemic absorption from the eye is very low, so fetal or infant exposure is expected to be minimal, but patients should still discuss use with their obstetric or pediatric provider.
• Children and older adults: Safety and effectiveness have not been established in pediatric patients; no major safety differences have been seen between younger and older adults.

Relative safety compared with similar drugs: Loteprednol-based drops like Inveltys are designed to be rapidly broken down after exerting a local effect, and clinical experience suggests they may cause fewer or smaller increases in eye pressure than some older ophthalmic steroids, but all steroid eye drops carry risks of pressure rise, infection, and delayed healing.

Reporting side effects and staying informed: Patients in the United States can report suspected side effects to the FDA’s MedWatch program (online or by calling 1-800-FDA-1088), and can check FDA or manufacturer safety updates for new information about risks.

Drug and product interactions:

• Because Inveltys acts mainly in the eye and systemic absorption is very low, significant interactions with most oral or injected medicines are unlikely.
• Tell your eye-care professional about all prescription and over-the-counter eye drops you use; avoid adding other steroid eye drops unless specifically instructed, as this can increase the risk of side effects.
• If you use multiple eye products (drops or ointments), separate them by at least 5 minutes to avoid washing one out with another.
• Do not wear soft contact lenses while putting in the drops; the preservative (benzalkonium chloride) can be absorbed by lenses, so remove them before dosing and wait at least 15 minutes before reinserting.

Precautions and conditions needing extra care:

• Existing eye infections (bacterial, viral such as herpes simplex, or fungal) or a history of herpes eye disease: steroids may worsen these and require very careful specialist supervision if used at all.
• Glaucoma, ocular hypertension, or a strong family history of glaucoma: you may be at higher risk for steroid-induced eye pressure increases.
• Thinning of the cornea or sclera: topical steroids can, in rare cases, contribute to perforation in severely thinned tissue.
• Use in children: not established as safe or effective; specialists may consider alternatives or very cautious use in selected cases.

Monitoring needs: If Inveltys is used for 10 days or longer, your eye-care professional may check your intraocular pressure and examine the eye to watch for infection, delayed healing, or other steroid-related effects; more frequent monitoring may be needed if you have glaucoma or other high-risk conditions.

Q: What is Inveltys used for?
A: Inveltys is a prescription corticosteroid eye drop used to reduce inflammation and pain after eye surgery, such as cataract surgery, in adults.

Q: How long do I need to use Inveltys?
A: The usual course is 1 to 2 drops in the operated eye twice a day for about 2 weeks after surgery, starting the day after surgery, unless your eye doctor gives you a different schedule.

Q: How quickly will my eye feel better with Inveltys?
A: Many people notice less pain within a few days and gradual improvement in redness and swelling over the 2-week treatment period, though exact timing varies by person and type of surgery.

Q: Can I use Inveltys if I wear contact lenses?
A: You should remove soft contact lenses before putting in Inveltys and wait at least 15 minutes before putting them back in, and you should follow your surgeon’s instructions about when it is safe to resume contact lens wear after surgery.

Q: Is Inveltys safe during pregnancy or breastfeeding?
A: Only very small amounts, if any, reach the bloodstream after eye use, so fetal or infant exposure is expected to be minimal, but you should still discuss the risks and benefits with your obstetrician or pediatrician before using it.

Q: What should I do if I forget a dose?
A: Use the missed dose as soon as you remember, but if it is almost time for your next scheduled dose, skip the missed one and continue with your regular dosing—do not use extra drops to make up for it.

Storage: Store the bottle upright at room temperature (about 59°F to 77°F / 15°C to 25°C), keep it tightly closed when not in use, do not freeze it, and do not use it if the tamper-evident seal is broken.

Disposal: Keep out of reach of children, do not share the bottle with anyone else, and when your course of treatment is finished or the drops expire, discard the bottle in household trash or follow your pharmacist’s local guidance for medicine take-back programs (do not pour into sinks or toilets unless specifically instructed).